Quality of life and symptoms of anxiety and depression of patients receiving cancer chemotherapy: longitudinal study

2.50
Hdl Handle:
http://hdl.handle.net/2336/88713
Title:
Quality of life and symptoms of anxiety and depression of patients receiving cancer chemotherapy: longitudinal study
Authors:
Saevarsdottir, Thorunn; Fridriksdottir, Nanna; Gunnarsdottir, Sigridur
Citation:
Cancer Nurs. 2010, 33(1):E1-E10
Issue Date:
1-Feb-2010
Abstract:
The overall survival gain of cancer chemotherapy is estimated to be small, and some claim that it rarely improves quality of life (QOL). The purpose of this population-based study was to describe QOL and symptoms of anxiety and depression, over time, in a group of Icelandic cancer patients receiving chemotherapy. Quality of life was measured with the Icelandic version of Cancer Rehabilitation Evaluation System, Short Form (CARES-SF), and symptoms of anxiety and depression, with the Icelandic version of Hospital Anxiety and Depression Scale (HADS). Enrolled into the study were 144 patients, 90 women and 54 men; mean (SD) age was 55 (12.1) years. Although QOL was found relatively good during the period of chemotherapy, it was significantly worse after 3 and 6 months compared to baseline. Quality of life was found worst in the sexual and physical domains. At all time points, a significant association was found between symptoms of anxiety and depression and QOL with those reporting symptoms of either anxiety or depression experiencing worse QOL. The good QOL found during the period of chemotherapy is a positive finding. The results, however, call for an intense assessment, over time, of physical symptoms, anxiety, and depression, as well as sexuality issues.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field
Additional Links:
http://dx.doi.org/10.1097/NCC.0b013e3181b4adb5

Full metadata record

DC FieldValue Language
dc.contributor.authorSaevarsdottir, Thorunnen
dc.contributor.authorFridriksdottir, Nannaen
dc.contributor.authorGunnarsdottir, Sigriduren
dc.date.accessioned2010-01-05T11:51:27Z-
dc.date.available2010-01-05T11:51:27Z-
dc.date.issued2010-02-01-
dc.date.submitted2010-01-05-
dc.identifier.citationCancer Nurs. 2010, 33(1):E1-E10en
dc.identifier.issn1538-9804-
dc.identifier.pmid20010331-
dc.identifier.doi10.1097/NCC.0b013e3181b4adb5-
dc.identifier.urihttp://hdl.handle.net/2336/88713-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractThe overall survival gain of cancer chemotherapy is estimated to be small, and some claim that it rarely improves quality of life (QOL). The purpose of this population-based study was to describe QOL and symptoms of anxiety and depression, over time, in a group of Icelandic cancer patients receiving chemotherapy. Quality of life was measured with the Icelandic version of Cancer Rehabilitation Evaluation System, Short Form (CARES-SF), and symptoms of anxiety and depression, with the Icelandic version of Hospital Anxiety and Depression Scale (HADS). Enrolled into the study were 144 patients, 90 women and 54 men; mean (SD) age was 55 (12.1) years. Although QOL was found relatively good during the period of chemotherapy, it was significantly worse after 3 and 6 months compared to baseline. Quality of life was found worst in the sexual and physical domains. At all time points, a significant association was found between symptoms of anxiety and depression and QOL with those reporting symptoms of either anxiety or depression experiencing worse QOL. The good QOL found during the period of chemotherapy is a positive finding. The results, however, call for an intense assessment, over time, of physical symptoms, anxiety, and depression, as well as sexuality issues.en
dc.language.isoenen
dc.relation.urlhttp://dx.doi.org/10.1097/NCC.0b013e3181b4adb5en
dc.subject.meshNeoplasmsen
dc.subject.meshDepressionen
dc.subject.meshQuality of Lifeen
dc.subject.meshAdulten
dc.subject.meshDrug Therapyen
dc.titleQuality of life and symptoms of anxiety and depression of patients receiving cancer chemotherapy: longitudinal studyen
dc.typeArticleen
dc.contributor.departmentLandspitali University Hospital, Hringbraut, 101 Reykjavik, Iceland. torunnsa@landspitali.isen
dc.identifier.journalCancer nursingen

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.